D Barrett

460 total citations
21 papers, 367 citations indexed

About

D Barrett is a scholar working on Immunology and Allergy, Molecular Biology and Physiology. According to data from OpenAlex, D Barrett has authored 21 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology and Allergy, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in D Barrett's work include Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (8 papers) and Muscle Physiology and Disorders (6 papers). D Barrett is often cited by papers focused on Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (8 papers) and Muscle Physiology and Disorders (6 papers). D Barrett collaborates with scholars based in Canada, United States and United Kingdom. D Barrett's co-authors include Peter Small, E. Spanos, I. MacIntyre, J. Wesley Pike, Mark R. Haussler, Saul Frenkiel, Louise Rochon, Shaun Cote, Sanela Bilic and George G. Nomikos and has published in prestigious journals such as Nature, Neurology and Biochemical Journal.

In The Last Decade

D Barrett

20 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Barrett Canada	8	119	100	97	94	70	21	367
M Fujimoto Japan	9	99 0.8×	36 0.4×	45 0.5×	64 0.7×	68 1.0×	10	410
Rhesa Dykes United States	7	95 0.8×	28 0.3×	123 1.3×	11 0.1×	116 1.7×	10	366
M C de Jong Netherlands	7	10 0.1×	73 0.7×	150 1.5×	37 0.4×	41 0.6×	11	359
D Zemková Czechia	13	17 0.1×	109 1.1×	25 0.3×	26 0.3×	95 1.4×	32	356
Myung S. Ko United States	12	44 0.4×	28 0.3×	154 1.6×	10 0.1×	42 0.6×	23	388
Roger Long United States	10	38 0.3×	121 1.2×	29 0.3×	10 0.1×	210 3.0×	14	377
Hirofumi Makino Japan	6	81 0.7×	49 0.5×	12 0.1×	17 0.2×	71 1.0×	8	382
Weiwei Hu China	12	32 0.3×	32 0.3×	91 0.9×	26 0.3×	148 2.1×	21	463
Vanessa Suárez Spain	12	24 0.2×	21 0.2×	33 0.3×	24 0.3×	93 1.3×	29	422
Atsushi SEYAMA Japan	10	53 0.4×	23 0.2×	26 0.3×	11 0.1×	123 1.8×	35	348

Countries citing papers authored by D Barrett

Since Specialization

Citations

This map shows the geographic impact of D Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Barrett more than expected).

Fields of papers citing papers by D Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Barrett. The network helps show where D Barrett may publish in the future.

Co-authorship network of co-authors of D Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of D Barrett. A scholar is included among the top collaborators of D Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Barrett. D Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2024). Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3. Neurology. 102(5). e209151–e209151. 19 indexed citations

Pokrzywinski, Robin, Hemal Shah, Nathalie Kertesz, et al.. (2023). Treatment Effects Among Patients with Type 2 and Type 3 SMA Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial (P2-8.010). Neurology. 100(17_supplement_2). 1 indexed citations

Barrett, D, et al.. (2021). A Phase 2 Study to Evaluate the Efficacy and Safety of SRK-015 in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): A Study Update (1963). Neurology. 96(15_supplement).

Barrett, D, Sanela Bilic, Yung Chyung, et al.. (2021). A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. Advances in Therapy. 38(6). 3203–3222. 30 indexed citations

Barrett, D, Shaun Cote, George G. Nomikos, et al.. (2021). SMA - TREATMENT. Neuromuscular Disorders. 31. S134–S134. 1 indexed citations

Kalra, Ashish, Shaun Cote, D Barrett, et al.. (2019). P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans. Neuromuscular Disorders. 29. S85–S85. 3 indexed citations

Small, Peter & D Barrett. (1995). Evaluation of dust and dust mite nasal provocation.. PubMed. 75(6 Pt 1). 501–6. 4 indexed citations

Small, Peter & D Barrett. (1994). Nonspecific nasal reactivity and smoking.. PubMed. 73(2). 114–6. 4 indexed citations

Small, Peter, et al.. (1994). Effects of intensity of early response to allergen on the late phase of both the nose and skin.. PubMed. 73(3). 252–8. 7 indexed citations

10.

Small, Peter, et al.. (1992). Does nasal provocation play a role in the diagnosis and management of ragweed-induced allergic rhinitis?. PubMed. 68(3). 274–8. 3 indexed citations

11.

Small, Peter & D Barrett. (1991). Effects of high doses of topical steroids on both ragweed and histamine-induced nasal provocation.. PubMed. 67(5). 520–4. 10 indexed citations

12.

Small, Peter, et al.. (1990). Effects of azatadine, terfenadine, and astemizole on allergen-induced nasal provocation.. PubMed. 64(2 Pt 1). 129–31. 5 indexed citations

13.

Small, Peter, et al.. (1990). Relationships among ragweed skin tests and both allergen specific and nonspecific nasal provocation.. PubMed. 65(3). 185–8. 4 indexed citations

14.

Small, Peter & D Barrett. (1988). 28 Effects of azatadine, terfenadine, and astemizole on allergen induced nasal provocation. Journal of Allergy and Clinical Immunology. 81(1). 175–175. 1 indexed citations

15.

Small, Peter, et al.. (1985). Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST.. PubMed. 55(5). 736–9. 50 indexed citations

16.

Small, Peter, et al.. (1985). Measurement of antigen-specific IgE in nasal secretions of patients with perennial rhinitis.. PubMed. 55(1). 68–71. 13 indexed citations

17.

Small, Peter, et al.. (1983). Venom immunotherapy--a critical evaluation of in vitro techniques.. PubMed. 50(4). 256–9. 2 indexed citations

18.

Small, Peter, et al.. (1982). Chronic urticaria and angioedema. Clinical & Experimental Allergy. 12(2). 131–136. 33 indexed citations

19.

Spanos, E., et al.. (1978). Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell cultures. Biochemical Journal. 174(1). 231–236. 44 indexed citations

20.

Spanos, E., et al.. (1978). Effect of growth hormone on vitamin D metabolism. Nature. 273(5659). 246–247. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact